AI Science Tracker
EN

Beijing StoneWise Technology Co Ltd

1 discovery from 2023

Discoveries

Deep learning model accurately classifies metastatic tumors from primary tumors based on mutational signatures

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: MetaWise uses mutational-signature features from tumor sequencing to classify metastatic versus primary tumors across large and external cohorts; this is a specific genomic classification result with limited paired-tumor validation.

Technology: Methods use a deep neural network on WES/WGS mutational signatures and compare with conventional and deep-learning baselines.

Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods use a deep neural network on WES/WGS mutational signatures and compare with conventional and deep-learning baselines.
Limitation / still unknown
The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41598-023-35842-w.pdf · https://pubmed.ncbi.nlm.nih.gov/37253775/

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.